NYSE · BFLYHealthcareX-Ray Equipment

Butterfly Network financials

$9.10−0.55%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
FY24
Dec 31
FY23
Dec 31
FY22
Dec 31
FY21
Dec 31
Revenue$97.6M$82.1M$65.9M$73.4M$62.6M
Gross profit$45.7M$48.8M$16.9M$39.5M$17.1M
Gross margin46.9%59.5%25.6%53.8%27.3%
Operating income-$86.4M-$74.4M-$145.6M-$193.0M-$192.7M
Net income-$77.1M-$72.5M-$133.7M-$168.7M-$32.4M
Net margin−79.0%−88.3%−202.9%−229.9%−51.8%
Diluted EPS$-0.31$-0.34$-0.65$-0.84$-0.19
EBITDA-$78.3M-$64.1M-$135.0M-$187.1M-$192.7M
Operating cash flow-$12.7M-$41.7M-$98.8M-$169.1M-$189.2M
Free cash flow-$16.0M-$44.4M-$104.6M-$187.4M-$197.1M
Diluted shares247.1M211.7M205.4M199.8M173.8M

Balance sheet

Period endDec 31Dec 31Dec 31Dec 31Dec 31
Cash & equivalents$150.5M$88.8M$134.4M$162.6M$422.8M
Short-term investments$0.00$0.00$0.00$75.3M—
Total debt$0.00$0.00$0.00$0.00$0.00
Total assets$296.5M$256.1M$304.3M$417.6M$572.0M
Total liabilities$100.6M$87.3M$84.2M$92.2M$124.3M
Shareholders' equity$196.0M$168.8M$220.1M$325.4M$447.7M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology